At $127.8 billion, the annual cost of caring for patients with chronic inflammatory/autoimmune disease has surpassed the cost of treating cancer. Inflammatory disorder is the #1 specialty drug spend in U.S. There is widespread clinical practice variation and lack of national standards. Demand for rheumatologists and neurologists exceeds supply and will double the supply by 2030, creating a burden on primary care. CrossBridge is a software platform to connect physicians and payers to deliver evidence-based care with cost efficiency while improving chronic inflammatory disease outcomes. The customer is the payer and it is available to physician practices at no cost. It is an independent, third party solution that spans the gap between payers and providers, with evidence-based disease libraries at treatment level and treatment plans delivered digitally between provider and payer for pre-authorization and transparency at time of prescribing. CrossBridge provides a better line of sight for all stakeholders and a path to Value-Based Care. CrossBridge began as a result of Bill Conlan's personal experience and seeing many others with autoimmune disease challenged by the U.S. healthcare system. Bill has personal experience with ankylosing spondylitis and also has family members with rheumatoid arthritis and multiple sclerosis.